Jeetinder Singh Mahal

Officer, Jasper Therapeutics, Inc.

Companies

Jasper Therapeutics, Inc.Board member Feb 10, 2026 to now¹
Jasper Therapeutics, Inc.Chief executive officer Feb 10, 2026 to now¹
Jasper Therapeutics, Inc.President Feb 10, 2026 to now¹
Jasper Therapeutics, Inc.Chief operating officer Mar 23, 2022 to Jul 22, 2026²
Jasper Therapeutics, Inc.Officer Oct 1, 2021 to Jun 13, 2023³
Jasper Therapeutics, Inc.Chief financial officer Mar 23, 2022 to Mar 23, 2022²

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Dec 12, 2024Sold 900 shares at $22.11 of Jasper Therapeutics, Inc.⁴
Dec 12, 2024Exercised options 900 shares at $7.10 of Jasper Therapeutics, Inc.⁴
Sep 12, 2024Sold 900 shares at $21.23 of Jasper Therapeutics, Inc.⁵
Sep 12, 2024Exercised options 900 shares at $7.10 of Jasper Therapeutics, Inc.⁵
Jun 12, 2024Sold 900 shares at $24.16 of Jasper Therapeutics, Inc.⁶
Jun 12, 2024Exercised options 900 shares at $7.10 of Jasper Therapeutics, Inc.⁶
Mar 12, 2024Sold 900 shares at $26.44 of Jasper Therapeutics, Inc.⁷
Mar 12, 2024Exercised options 900 shares at $7.10 of Jasper Therapeutics, Inc.⁷
Oct 12, 2023Shares withheld for tax 37,126 shares at $0.85 of Jasper Therapeutics, Inc.⁸
Jun 13, 2023Sold 9,000 shares at $1.66 of Jasper Therapeutics, Inc.⁹
Jun 13, 2023Exercised options 9,000 shares at $0.71 of Jasper Therapeutics, Inc.⁹
Apr 12, 2023Shares withheld for tax 37,126 shares at $1.46 of Jasper Therapeutics, Inc.¹⁰
Oct 12, 2022Granted 214,722 shares of Jasper Therapeutics, Inc.¹¹

The numbers on this page point here. Each one links to the record it came from.